Hints and tips:
Related Special Reports
Companies have yet to provide investors with convincing post-pandemic strategies
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...It also paid $4.9bn this month for Alpine Immune Sciences, which is developing a treatment for an autoimmune kidney disease....
...Rather he acquired shares of another life sciences company Incyte. Its shares jumped 8 per cent on the Medivation deal. Panuwat quickly cashed out Incyte call options for a $100,000 profit....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
Millions of Paxlovid pills have gone unused as tight controls restrict access
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
...A blockbuster drug developed by US pharmaceutical group Merck to treat Covid-19 has been linked to mutations transmitted when the coronavirus spreads between patients, a finding that will increase scrutiny...
...Roivant Sciences, which has a portfolio of companies, was founded in 2014 by Vivek Ramaswamy, who is now running for US president....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US
...“Thaysen is a top leader at one of the top five life science companies and is well known by the life sciences and technology investor base . . . which should help on the communication front.”...
...He said the acquisition may signal a shift in activity in the pharmaceutical sector towards more aggressive deployment of cash to scoop up biotech companies....
...In May, the Pharmaceutical Supply Chain Initiative, a lobby set up by large pharmaceutical companies, said its members should stop sourcing blood from the two Asian horseshoe crab species most at risk....
...The reforms have been fiercely resisted by the pharmaceutical industry, which has warned they would cripple innovation and hinder development of life-saving medicines....
...The New Jersey pharmaceutical titan’s share price has doubled in the past five years, well ahead of the wider S&P 500 index....
...Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...It also generated excitement across the pharmaceutical industry, which is enticed by the prospect of selling medicines to the more than 50mn people worldwide who suffer from the disease....
FTC warns acquisition would hurt competition in the market for early detection cancer tests
Company’s shares jump after activist investor launches proxy battle
...Over the medium to long term, the market for this new class of GLP-1 drugs is expected to become fiercely competitive as rival pharmaceutical companies launch new therapies....
...But 2022 should also be remembered for pharmaceutical advances. The industry that created the pandemic-ending Covid-19 vaccines is promising better treatments for cancer, obesity and Alzheimer’s....
Founding directors say political wrangling causing delays to potentially life-saving blood test
International Edition